Find and engage the voices that matter
KOL Mapping and Engagement for healthcare and life sciences
Identify, profile and map the influence networks of key opinion leaders and digital opinion leaders by therapy area and geography.
HealthcareMarketResearch delivers kol mapping and engagement for pharmaceutical, biotech, medical device, diagnostics and digital health companies, as well as consultancies and investors.
Projects run from our India headquarters with a global network of 5,000+ market researchers, so you get senior attention, round-the-clock delivery and local fieldwork in every major market.
What you receive
- KOL identification
- Influence network maps
- Profiles and tiering
- Engagement planning
Common use cases
- Medical affairs planning
- Clinical trial site selection
- Launch advocacy
- Scientific communications
At a glance
KOL Mapping and Engagement: the short version
Turnaround, typical scope, audiences, coverage and deliverables for kol mapping and engagement — the answer-first version, before you write a brief.
- Turnaround
- Scoping in 24–48 hours, a first tiered map in 5–10 business days per therapy area
- Typical scope
- 50–500 individuals profiled per therapy area and geography
- Who we reach
- Academic chairs, trial investigators, guideline authors, society office-bearers, DOLs
- Coverage and languages
- 100+ Indian cities, plus remote sessions worldwide; English, Hindi and major regional languages
- What you receive
- Tiered KOL profiles, influence network map, engagement plan, agreed refresh cadence
- How it runs
- Desk research and primary validation calls, then a map we keep current for you
Scopes are typical, not fixed packages — every project is sized to your brief. Studies follow EphMRA, BHBIA and Insights Association guidance, with GDPR, HIPAA and DPDP-aligned handling of participant data.
How a project runs
Five steps from brief to readout
Every kol mapping and engagement project follows the same path, with a named HMR lead accountable at each step.
- 01
Define the universe
Therapy area, line of therapy, geography and the kind of influence that matters: clinical practice, guidelines, trials, payer opinion or patient audience.
24–48 hours
- 02
Identify candidates
Publications, trial registries, guideline authorship, society and conference faculty, hospital affiliations and public digital activity screened into one candidate list.
Multi-source
- 03
Profile and tier
Each individual is profiled on practice, research, affiliations, prior engagement and reach, then tiered against criteria you have signed off rather than ours.
Your criteria
- 04
Map the influence
Co-authorship, referral, mentorship and society relationships are drawn as a network, so you can see who moves whom instead of reading a ranked list.
Network view
- 05
Engagement plan and refresh
Who to approach, in what order, by which function and with what ask, and how often the map is refreshed as trials read out and roles change.
Refreshed on cadence
Who we reach
Stakeholders we recruit for kol mapping and engagement
Screened from our 5,000+ network and verified panels across 100+ Indian cities.
Academic and clinical leaders
- Department and division chairs
- Professors and unit heads
- Guideline committee authors
- Centre-of-excellence directors
- Fellowship programme directors
Trial and research network
- Principal investigators
- Site coordinators and study nurses
- CRO and site-network leads
- Registry and biobank custodians
- Translational research leads
Society and policy voices
- Medical society office-bearers
- Conference scientific committee members
- Journal editors and reviewers
- Public health advisors
- State chapter presidents
Digital opinion leaders
- Clinician educators with large followings
- Podcast and webinar hosts
- Online community moderators
- Patient-facing clinician creators
- Medical content reviewers
Rising and emerging voices
- Early-career investigators
- High-recruiting trial sites
- First authors on pivotal data
- Tier-2 city practice builders
- Private-sector specialists with volume
Payer and institutional influencers
- Formulary committee chairs
- Pharmacy and therapeutics members
- Insurance medical directors
- Procurement decision-makers
- Scheme and policy advisors
Method comparison
KOL Mapping and Engagement compared with the alternatives
The same question can be answered several ways. This is how kol mapping and engagement differs from the methods clients usually weigh it against — KOL Mapping and Engagement is the highlighted column.
| KOL Mapping and Engagement | Advisory Boards | Expert Calls | Secondary Market Research | |
|---|---|---|---|---|
| Speed | First map in 5–10 business days | Designed once, then quarterly | Experts in 24–48 hours | Desk work starts immediately |
| Typical sample | 50–500 individuals profiled | 6–12 standing members | 5–15 calls, one expert each | No respondents; published sources |
| Depth of insight | Profiles plus influence networks | Cumulative and relationship-based | Deep and unstructured, you can probe | Breadth first, sourced throughout |
| Best for | Knowing who actually influences practice | Standing counsel across several quarters | Fast senior judgement on a live decision | A landscape built from published evidence |
| Typical output | Tiered profiles, network map, plan | Session decks, minutes, action tracker | Recording, transcript, takeaways memo | Sourced findings report, landscape view |
| Runs in person in India |
Compliance
How we keep kol mapping and engagement compliant
Healthcare research carries obligations that general market research does not. These apply to every project, in every market.
Industry codes
EphMRA, BHBIA, Insights Association and ESOMAR guidance on how healthcare research is conducted.
Adverse events
Trained adverse event reporting on every healthcare interview, routed to your pharmacovigilance contact.
Data protection
GDPR, HIPAA and India's DPDP Act. Consent is captured before any recording or transcription.
Conflicts and confidentiality
Every participant is screened against your exclusion list and engaged under confidentiality terms.
Is this the right fit?
When to use kol mapping and engagement — and when not to
We would rather point you at the right method than sell you this one. Here is where kol mapping and engagement earns its place, and where something else does the job better.
Choose this when
- A launch or a trial needs the right advocates identified before engagement starts
- Medical affairs needs to know who influences practice, not who publishes most
- You are entering a therapy area or a market where you have no relationships yet
- Site selection, advisory boards and publications planning all need one shared source
Consider something else when
- You already have the names and need their opinion on a specific question
- What you need is a standing body that meets and advises on a cadence
- The question is about market size or prescribing behaviour, not influence
- A one-off literature and pipeline scan would be enough
Alternatives
Where another method fits better
Each of these answers a different kind of question. Tell us the decision and we will recommend the right one, even when it is not this service.
KOL Mapping and Engagement across India
By industry
FAQs
What is kol mapping and engagement in healthcare market research?+
KOL Mapping and Engagement is one of the ways HealthcareMarketResearch connects pharma, biotech, medtech and healthcare clients with verified physicians, payers and industry experts to answer strategic questions. Identify, profile and map the influence networks of key opinion leaders and digital opinion leaders by therapy area and geography.
How quickly can kol mapping and engagement start?+
Most projects start within 24–48 hours of a confirmed brief, drawing on our 5,000+ network. Scoping in 24–48 hours, a first tiered map in 5–10 business days per therapy area.
Where do you offer kol mapping and engagement?+
Across 100+ Indian cities — from Mumbai, Delhi NCR and Bengaluru to tier 2 and tier 3 hubs — delivered remotely from our Pune headquarters.
What is a typical kol mapping and engagement scope?+
50–500 individuals profiled per therapy area and geography. You receive: KOL identification, Influence network maps, Profiles and tiering, Engagement planning. Everything is sized to the brief rather than sold as a fixed package.
Who can you reach for kol mapping and engagement?+
Academic and clinical leaders, Trial and research network, Society and policy voices, Digital opinion leaders, Rising and emerging voices, Payer and institutional influencers. Each group is screened on specialty, setting and experience before anyone joins a study.
What is the difference between kol mapping and engagement and advisory boards?+
KOL Mapping and Engagement is best for knowing who actually influences practice, with 50–500 individuals profiled and profiles plus influence networks. Advisory Boards is best for standing counsel across several quarters. If both apply, the two are often run in sequence.
Other services
Have a healthcare question that needs real answers?
Brief us today and talk to a verified expert this week.